Clinical Trials Browser

Phase 2 × Fallopian Tube Neoplasms × eribulin × Clear all

NCT00334893 2017-11-29

Eribulin Mesylate in Treating Patients With Recurrent Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

Phase 2 Completed

74 enrolled 7 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms